Rebase Lifescience Private Limited

New pharmaceutical company specializing in raw materials and related products.

2019 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Rebase Lifescience Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 10.00 Cr
  • Company Age 6 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 10.50 Cr
  • Revenue Growth %
  • Net Worth -34.87%
  • Total Assets 34.94%

About Rebase Lifescience

Rebase Lifescience Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 January 2019 (Six years and one month 15 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 10.00 Cr.

The company currently has active open charges totaling ₹10.50 Cr.

Minesh Suthar, Miteshkumar Patel, and Yogesh Shah serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    rebaselifescience.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24290GJ2019PTC106089

  • Company No.

    106089

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    15 Jan 2019

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Rebase Lifescience?

Board Members (3)

NameDesignationAppointment DateStatus
Minesh Suthar Country flag representing In Director 24-Dec-2020Current
Miteshkumar Patel Country flag representing In Director 15-Jan-2019Current
Yogesh Shah Country flag representing In Additional Director 31-May-2024Current

Financial Performance of Rebase Lifescience.

Rebase Lifescience Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.87%.

Rebase Lifescience revenue growth over time
Rebase Lifescience profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
34.94%
Profit or Loss
Net Worth
-34.87%
EBITDA

What is the Ownership and Shareholding Structure of Rebase Lifescience?

In 2022, Rebase Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹10.50 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of India : 10.50 Cr

Latest Charge Details

DateLenderAmountStatus
25 Jan 2021State Bank Of India₹5.25 CrOpen
22 Jan 2021State Bank Of India₹5.25 CrOpen

How Many Employees Work at Rebase Lifescience?

Rebase Lifescience has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Rebase Lifescience Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rebase Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rebase Lifescience's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rebase Lifescience

Recent activity within the organization

  • Annual General Meeting

    Rebase Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Yogesh Shah was appointed as a Additional Director was appointed as a Additional Director on 31 May 2024 & has been associated with this company since 9 months 1 day .

  • Balance Sheet

    Rebase Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

  • Charges

    A charge with State Bank Of India amounted to Rs. 5.25 Cr with Charge ID 100415278 was registered on 25 Jan 2021.

  • Charges

    A charge with State Bank Of India amounted to Rs. 5.25 Cr with Charge ID 100415286 was registered on 22 Jan 2021.

  • Director Appointment

    Minesh Manharlal Suthar was appointed as a Director was appointed as a Director on 24 Dec 2020 & has been associated with this company since 4 years 2 months .

Frequently asked questions

  • What is the Incorporation or founding date of Rebase Lifescience Private Limited?

    Rebase Lifescience Private Limited was incorporated on 15 Jan 2019.

  • What is authorized share capital and paid-up capital of Rebase Lifescience Private Limited?

    The authorized share capital of Rebase Lifescience Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 10.00 Cr.

  • Who are the current board members & directors of Rebase Lifescience Private Limited?

    Currently 3 directors are associated with Rebase Lifescience Private Limited.

    • Minesh Manharlal Suthar
    • Miteshkumar Gordhanbhai Patel
    • Yogesh Shah

  • What is the registered address of Rebase Lifescience Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Rebase Lifescience Private Limited is Plot No.11 12 Block No.6, Nr. Amrut Dairy India, Lalpur, Gujarat, 382430.

  • What is the corporate identification number (CIN) and company number of Rebase Lifescience Private Limited?

    The corporate identification number (CIN) of Rebase Lifescience Private Limited is U24290GJ2019PTC106089 and the company number is 106089 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Rebase Lifescience Private Limited?

    The Official website of Rebase Lifescience Private Limited is https://www.rebaselifescience.com

  • How many employees does Rebase Lifescience Private Limited currently have?

    As Per 2022 financial reports, 25 employees are currently employed by Rebase Lifescience Private Limited.

  • What change has been observed in the net worth of Rebase Lifescience Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Rebase Lifescience Private Limited has experienced an downturn of -34.87%.

  • What are the total open charges for Rebase Lifescience Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Rebase Lifescience Private Limited amount to ₹ 10.50 Cr.

  • When was the last Balance Sheet of Rebase Lifescience Private Limited filed with the ROC?

    The most recent Balance Sheet for Rebase Lifescience Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development